Related Experiment Video
Updated: May 25, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.4K
Expanding the Clinical Spectrum Associated with the Recurrent Arg203Trp Variant in PACS1: An Italian Cohort Study
Stefano Pagano1, Diego Lopergolo2,3, Alessandro De Falco1
1Molecular Medicine, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
Genes
|February 26, 2025
Summary
Schuurs-Hoeijmakers syndrome (SHMS), a PACS1 neurodevelopmental disorder, is characterized by intellectual disability and distinct facial features. This study details 10 new Italian patients, aiding in earlier diagnosis and management.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
- Rare Diseases
Background:
- Schuurs-Hoeijmakers syndrome (SHMS), also known as PACS1 neurodevelopmental disorder, is a rare genetic condition.
- It is associated with intellectual disability, craniofacial abnormalities, and congenital malformations.
- Previous studies identified PACS1 gene variants in 63 patients.
Purpose of the Study:
- To describe 10 new Italian patients with SHMS.
- To detail the clinical features of SHMS.
- To facilitate the diagnosis and management of SHMS.
Main Methods:
- Clinical evaluation by geneticists and child neurologists.
- Phenotypic data coded using Human Phenotype Ontology (HPO) terms.
- Identification of the recurrent p.(Arg203Trp) PACS1 variant via exome sequencing and a novel PCR-RFLP strategy.
Main Results:
- Detailed clinical phenotyping of 10 Italian SHMS patients with the p.(Arg203Trp) variant.
- Identified characteristic facial features: thick eyebrows, down-slanting palpebral fissures, ocular hypertelorism, low-set ears, thin upper lip, wide mouth.
- These features aid in diagnosis through clinical evaluation, neuroimaging, and neuropsychological assessment.
Conclusions:
- The study highlights specific clinical features aiding SHMS recognition in Italian children.
- Improved diagnostic capabilities can lead to better management strategies.
- Findings contribute to precision medicine approaches in medical genetics for SHMS.

